Roche: Oxford BioTherapeutics inks multiyear collaboration with Roche to discover novel targets for antibodybased therapeutics to treat cancer
Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno─oncology (IO) and antibody drug conjugate (ADC)─based therapies, announced a multi─year collaboration with Roche to
Read full article »
Roche is a Switzerland-based biotechnology company that discovers, develops, and provides diagnostic and pharmaceutical products and services for the healthcare sector.
Read more